The Patent Finder

Terms ending in 2039

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US D1,010,107Handheld Drug Delivery Device
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,251,743Method of Preventing Lamellar Silica Formation in Glass Container
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US D1,010,811Handheld Drug Delivery Device
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,541,103Interleukin-21 Mutein/ Anti-PD-1 Antibody Conjugates
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,738,110PAC1 Antibodies and Uses Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,248,043Methods for Treating a Headache Condition Using Anti-Human PAC1 Antibodies or Antigen-Binding Fragments Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,891,435Polynucleotides Encoding Monoclonal Antibodies Binding to Human Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor (PAC1) and Methods of Making Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,790,388Anti-Human PAC1 Antibodies or Antigen-Binding Fragments Thereof and Methods of Use Thereof for Inhibiting Vasodilation and Ameliorating a Headache Condition
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,541,183Device Activation Impact/Shock Reduction
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,516,111Direct Selection of Cells Expressing High Levels of Heteromeric Proteins Using Glutamine Synthetase Intragenic Complementation Vectors
In force
 · High confidence
Amgen Inc.In forceHigh confidence
75 more term ends in 2039 · Pro
10 of 85 patents shown. Soonest term end first, then patent number.
Pro members see all 85.
Upgrade to Pro
80 of these are in force and held by Amgen Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited